ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
재생의료용 이종이식편 시장 규모는 최근 급속도로 확대되고 있습니다. 2024년의 12억 6,000만 달러에서 2025년에는 14억 달러로, CAGR 10.8%의 성장이 전망되고 있습니다. 지난 수년간의 성장은 만성 질환의 유병률 증가, 세계 노인 인구 증가, 정형외과, 치과, 심혈관, 연부조직 질환의 발생률 상승, 재생의료에 대한 인지도와 수용성의 향상, 저침습 수술 및 외래 처치에 대한 수요 증가와 관련이 있습니다.
재생의료용 이종이식편 시장 규모는 향후 수년간 빠른 성장이 전망되고 있습니다. 2029년에는 20억 8,000만 달러에 달하고, CAGR은 10.5%를 나타낼 것으로 예측되고 있습니다. 예측기간의 성장은 의료 인프라 투자 확대, 이종이식편의 응용범위 확대, 스포츠 관련 상해, 교통사고, 외상 사례 증가, 연구개발 활동과 공동연구의 활성화, 규제와 환급 프레임워크의 강화에 의해 견인될 가능성이 있습니다. 예측기간의 주요 동향으로는 첨단기술의 통합, 복잡한 수술에서의 이종이식편 보급 확대, 이종이식편 및 생체재료의 혁신, 응용 분야의 확대, 지속적인 기술진보 등이 있습니다.
정형외과적 손상의 발생률 상승은 향후 수년간의 재생의료용 이종이식편 시장 성장의 견인역이 될 전망입니다. 뼈, 관절, 근육, 힘줄, 인대와 같은 근골격계 손상을 동반한 정형외과적 손상에는 일반적으로 골절, 탈구, 염좌, 파열 등이 포함됩니다. 이러한 손상 빈도 증가는 주로 비만과 과도한 체중 때문입니다. 이들은 뼈와 관절에 추가적인 기계적 스트레스를 주고 마모를 가속화하며 골절과 관절 변성의 위험을 높입니다. 재생의료 이종이식편은 뼈와 관절의 복구를 촉진하고 조직 재생을 지원하며 근골격 기능을 회복시키는 고급 동물 유래 생체 재료를 제공함으로써 증가하는 정형외과적 손상의 유병률을 낮추는 데 도움이 됩니다. 예를 들어 2024년 11월에 영국 노동안전보건청(HSE)이 발표한 보고서에 따르면 2024년에는 약 54만 3천명의 노동자가 직업성근골격계장애(MSDs)를 앓았으며, 이는 2023년 47만 3천명에서 증가한 수치입니다. 이 증가는 정형외과적 손상의 유병률 증가와 재생의료 솔루션에 대한 수요 증가를 부각시키고 있으며, 재생의료용 이종이식편 시장의 확대를 추진하고 있습니다.
재생의료용 이종이식편 시장을 선도하는 주요 기업은 신뢰성 높은 뼈 재생, 임플란트 생존율 향상, 최적의 조직 통합에 대한 수요 증가에 대응하기 위해 첨단 콜라겐 멤브레인 개발 등 기술 혁신에 주력하고 있습니다. 이 첨단 콜라겐 멤브레인은 생체적합성 및 흡수성 재료이며 뼈와 연조직의 치유를 지원하도록 설계되었습니다. 기존의 비흡수성 멤브레인은 제거에 2차 수술이 필요하지만, 고급 콜라겐 멤브레인은 뛰어난 조작성, 적응성 및 안정성을 제공합니다. 예를 들어 2025년 10월, 스위스에 본사를 둔 재생 바이오재료 기업인 가이스트리히 파마사는 입증된 Bio-Gide 기술을 기반으로 한 선진적인 콜라겐 멤브레인 "Geistlich Bio-Gide Forte"를 발매했습니다. 이 신제품은 강도와 안정성을 향상시키고, 쉽게 전개할 수 있으며, 결함 부위에 유연하게 적응합니다. 또한 수화 상태에서도 정밀한 절단이 가능합니다. 이 혁신은 복잡한 임상 처치를 용이하게 하고, 보다 신속하고 확실한 뼈, 조직 재생을 촉진하여 임플란트의 생존율을 향상시킵니다. Geistlich Bio-Gide Forte는 현재 북미에서 판매 중이며 유럽 시장으로의 전개도 진행 중입니다. 해당 제품은 다양한 수술 요구를 충족시키기 위해 여러가지 크기로 제공됩니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 재생의료용 이종이식편 시장 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 재생의료용 이종이식편 시장 : 성장률 분석
세계의 재생의료용 이종이식편 시장 실적 : 규모와 성장(2019-2024년)
세계의 재생의료용 이종이식편 시장 예측 : 규모와 성장(2024-2029년, 2034F)
세계의 재생의료용 이종이식편 시장 : 총 시장 규모(TAM)
제6장 시장 세분화
세계의 재생의료용 이종이식편 시장 : 이종이식편 유형별, 분석과 예측(2019-2024년, 2024-2029F, 2034F)
뼈 이종이식편
연골 이종이식편
진피 이종이식편
치과용 이종이식편
혈관 이종이식편
세계의 재생의료용 이종이식편 시장 : 제제별, 분석과 예측(2019-2024년, 2024-2029F, 2034F)
분말 형태
액체 형태
겔 형태
시트 형상
복합 형태
세계의 재생의료용 이종이식편 시장 : 이식원별, 분석과 예측(2019-2024년, 2024-2029F, 2034F)
돼지 유래 이종이식편
소 유래 이종이식편
말 유래 이종이식편
개 유래 이종이식편
세계의 재생의료용 이종이식편 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029F, 2034F)
정형외과 수술
치과 수술
심장혈관 수술
상처 치유
미용 성형
세계의 재생의료용 이종이식편 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029F, 2034F)
병원
외래수술센터(ASC)
전문 클리닉
연구기관
기타 최종 사용자
세계의 재생의료용 이종이식편 시장 세분화 : 뼈 이종이식편, 유형별, 분석과 예측(2019-2024년, 2024-2029F, 2034F)
피질골
해면골
탈회골 매트릭스
뼈 블록
뼈 팁
세계의 재생의료용 이종이식편 시장 세분화 : 연골 이종이식편, 유형별, 분석과 예측
관절 연골
반월판 연골
코 연골
이개 연골
세계의 재생의료용 이종이식편 시장 세분화 : 진피 이종이식편, 유형별, 분석과 예측(2019-2024년, 2024-2029F, 2034F)
무세포 진피 매트릭스
가교 진피 스캐폴드
비가교 진피 스캐폴드
복합 진피 이식편
세계의 재생의료용 이종이식편 시장 세분화 : 치과용 이종이식편, 유형별, 분석과 예측(2019-2024년, 2024-2029F, 2034F)
골대체용 과립
멤브레인 및 배리어
블록 이식편
소켓 보존 재료
세계의 재생의료용 이종이식편 시장 세분화 : 혈관 이종이식편, 유형별, 분석과 예측(2019-2024년, 2024-2029F, 2034F)
혈관 패치
혈관 이식편
심장판 이종이식편
심막 패치
제7장 지역별 및 국가별 분석
세계의 재생의료용 이종이식편 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029F, 2034F)
세계의 재생의료용 이종이식편 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029F, 2034F)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
재생의료용 이종이식편 시장 : 경쟁 구도
재생의료용 이종이식편 시장 : 기업 프로파일
Stryker Corporation : 개요, 제품 및 서비스, 전략 및 재무 분석
Zimmer Biomet Holdings Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Smith & Nephew plc : 개요, 제품 및 서비스, 전략 및 재무 분석
Dentsply Sirona : 개요, 제품 및 서비스, 전략 및 재무 분석
Arthrex Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Integra LifeSciences Corporation
Nobel Biocare
Organogenesis Holdings Inc.
Osstem Implant
MiMedx Group Inc.
Vericel Corporation
LifeNet Health
BioTissue Holdings Inc.
Geistlich Pharma AG
RTI Surgical Holdings Inc.
Tissue Regenix Group plc
Viscus Biologics
Botiss Biomaterials GmbH
Revivicor Inc.
Genoss Co. Ltd.
제32장 세계 시장의 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
재생의료용 이종이식편 시장(2029년) : 새로운 기회를 제공하는 국가
재생의료용 이종이식편 시장(2029년) : 새로운 기회를 제공하는 부문
재생의료용 이종이식편 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
CSM
영문 목차
영문목차
A regenerative xenograft is a biological graft sourced from a different species and designed to support and stimulate tissue regeneration in the recipient. It functions as a scaffold that encourages the patient's own cells to grow, repair, or replace damaged tissues. The primary goal of a regenerative xenograft is to enable natural healing and tissue restoration while eventually integrating into or being replaced by the patient's own tissue.
The main types of xenografts in regenerative xenograft include bone xenografts, cartilage xenografts, dermal xenografts, dental xenografts, and vascular xenografts. Bone xenografts are regenerative biomaterials obtained from animal bone-typically bovine or porcine-used to facilitate bone repair and regeneration in human orthopedic and dental procedures. These are available in formulations such as powdered form, liquid form, gel form, sheet form, and composite form, and are derived from sources including donor porcine xenografts, bovine xenografts, equine xenografts, and canine xenografts. They are used in applications such as orthopedic surgery, dental surgery, cardiovascular surgery, wound healing, and cosmetic surgery, and serve end users including hospitals, ambulatory surgical centers, specialty clinics, research institutes, and others.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.
The regenerative xenograft market research report is one of a series of new reports from The Business Research Company that provides regenerative xenograft market statistics, including regenerative xenograft industry global market size, regional shares, competitors with a regenerative xenograft market share, detailed regenerative xenograft market segments, market trends and opportunities, and any further data you may need to thrive in the regenerative xenograft industry. This regenerative xenograft market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The regenerative xenograft market size has grown rapidly in recent years. It will grow from $1.26 billion in 2024 to $1.40 billion in 2025 at a compound annual growth rate (CAGR) of 10.8%. The growth in the historic period can be linked to the increasing prevalence of chronic diseases, a rising global geriatric population, growing incidence of orthopedic, dental, cardiovascular, and soft-tissue conditions, increasing awareness and acceptance of regenerative therapies, and rising demand for minimally invasive surgeries and outpatient procedures.
The regenerative xenograft market size is expected to see rapid growth in the next few years. It will grow to $2.08 billion in 2029 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be driven by expanding investments in healthcare infrastructure, increasing applications of xenografts, rising cases of sports-related injuries, road accidents, and trauma, growing research and development activities and collaborations, and strengthening regulations and reimbursement frameworks. Major trends in the forecast period include the integration of advanced technologies, wider adoption of xenografts in complex surgical procedures, innovations in xenograft materials and biomaterials, expansion of application areas, and ongoing technological advancements.
The rising incidence of orthopedic injuries is expected to drive the growth of the regenerative xenograft market in the coming years. Orthopedic injuries, which involve damage to the musculoskeletal system-such as bones, joints, muscles, tendons, and ligaments-typically include fractures, dislocations, sprains, or tears. The increasing frequency of these injuries is largely due to obesity and excess body weight, which place added mechanical stress on bones and joints, accelerating wear and tear and increasing the risk of fractures and joint degeneration. Regenerative xenografts help address the growing prevalence of orthopedic injuries by offering advanced animal-derived biomaterials that promote bone and joint repair, support tissue regeneration, and restore musculoskeletal function. For example, in November 2024, the Health and Safety Executive (HSE), a UK-based national regulator for workplace health and safety, reported that approximately 543,000 workers suffered from work-related musculoskeletal disorders (MSDs) in 2024, up from 473,000 in 2023. This increase highlights the rising prevalence of orthopedic injuries and the growing demand for regenerative solutions, driving the expansion of the regenerative xenograft market.
Leading companies in the regenerative xenograft market are focusing on technological advancements, such as the development of advanced collagen membranes, to meet the rising demand for reliable bone regeneration, improved implant survival, and optimal tissue integration. These advanced collagen membranes are biocompatible, resorbable materials designed to support bone and soft tissue healing. Compared to traditional non-resorbable membranes, which require secondary surgery for removal, advanced collagen membranes offer superior handling, adaptability, and stability. For example, in October 2025, Geistlich Pharma, a Switzerland-based regenerative biomaterials company, launched Geistlich Bio-Gide Forte, an advanced collagen membrane based on its proven Bio-Gide technology. The new membrane features enhanced strength and stability, unfolds easily, adapts flexibly to defect sites, and can be precisely cut even when hydrated. This innovation facilitates complex clinical procedures and supports faster, more reliable bone and tissue regeneration, improving implant survival rates. Geistlich Bio-Gide Forte is currently available in North America, with a European market launch underway, and is offered in multiple sizes to meet diverse surgical needs.
In November 2024, RTI Surgical, a U.S.-based provider of contract development and manufacturing services (CDMO), acquired Collagen Solutions for an undisclosed amount. This acquisition allows RTI Surgical to expand its portfolio of soft-tissue and xenograft biomaterials by leveraging Collagen Solutions' expertise in bovine and porcine collagen. This move is aimed at accelerating access to high-growth therapeutic areas such as cardiac, sports medicine, orthopedic, and reconstructive surgery. Collagen Solutions is a US-based company that specializes in engineered medical-grade collagen and xenograft tissue products for original equipment manufacturers (OEMs).
Major companies operating in the regenerative xenograft market are Stryker Corporation, Zimmer Biomet Holdings Inc., Smith & Nephew plc, Dentsply Sirona, Arthrex Inc., Integra LifeSciences Corporation, Nobel Biocare, Organogenesis Holdings Inc., Osstem Implant, MiMedx Group Inc., Vericel Corporation, LifeNet Health, BioTissue Holdings Inc., Geistlich Pharma AG, RTI Surgical Holdings Inc., Tissue Regenix Group plc, Viscus Biologics, Botiss Biomaterials GmbH, Revivicor Inc., Genoss Co. Ltd.
North America was the largest region in the regenerative xenograft market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in regenerative xenograft report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the regenerative xenograft market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The regenerative xenograft market consists of sales of products such as dermal xenografts for skin repair, bone and dental xenografts for orthopedic and dental reconstruction, cartilage and meniscus xenografts for joint restoration, vascular xenografts for blood vessel replacement, and cardiac xenografts, including heart valves and pericardial tissues. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Regenerative Xenograft Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on regenerative xenograft market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for regenerative xenograft ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The regenerative xenograft market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type Of Xenograft: Bone Xenografts; Cartilage Xenografts; Dermal Xenografts; Dental Xenografts; Vascular Xenografts
2) By Formulation: Powdered Form; Liquid Form; Gel Form; Sheet Form; Composite Form
3) By Source Of Donor: Porcine Xenografts; Bovine Xenografts; Equine Xenografts; Canine Xenografts
4) By Application: Orthopedic Surgery; Dental Surgery; Cardiovascular Surgery; Wound Healing; Cosmetic Surgery
5) By End-User: Hospitals; Ambulatory Surgical Centers; Specialty Clinics; Research Institutes; Other End-Users
Subsegments:
1) By Bone Xenografts: Cortical Bone; Cancellous Bone; Demineralized Bone Matrix; Bone Blocks; Bone Chips
3. Regenerative Xenograft Market Trends And Strategies
4. Regenerative Xenograft Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Regenerative Xenograft Growth Analysis And Strategic Analysis Framework
5.1. Global Regenerative Xenograft PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Regenerative Xenograft Market Growth Rate Analysis
5.4. Global Regenerative Xenograft Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Regenerative Xenograft Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Regenerative Xenograft Total Addressable Market (TAM)
6. Regenerative Xenograft Market Segmentation
6.1. Global Regenerative Xenograft Market, Segmentation By Type Of Xenograft, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Bone Xenografts
Cartilage Xenografts
Dermal Xenografts
Dental Xenografts
Vascular Xenografts
6.2. Global Regenerative Xenograft Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Powdered Form
Liquid Form
Gel Form
Sheet Form
Composite Form
6.3. Global Regenerative Xenograft Market, Segmentation By Source Of Donor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Porcine Xenografts
Bovine Xenografts
Equine Xenografts
Canine Xenografts
6.4. Global Regenerative Xenograft Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Orthopedic Surgery
Dental Surgery
Cardiovascular Surgery
Wound Healing
Cosmetic Surgery
6.5. Global Regenerative Xenograft Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Research Institutes
Other End-Users
6.6. Global Regenerative Xenograft Market, Sub-Segmentation Of Bone Xenografts, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cortical Bone
Cancellous Bone
Demineralized Bone Matrix
Bone Blocks
Bone Chips
6.7. Global Regenerative Xenograft Market, Sub-Segmentation Of Cartilage Xenografts, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Articular Cartilage
Meniscal Cartilage
Nasal Cartilage
Auricular Cartilage
6.8. Global Regenerative Xenograft Market, Sub-Segmentation Of Dermal Xenografts, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Acellular Dermal Matrix
Crosslinked Dermal Scaffold
Non-Crosslinked Dermal Scaffold
Composite Dermal Grafts
6.9. Global Regenerative Xenograft Market, Sub-Segmentation Of Dental Xenografts, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Bone Substitute Granules
Membranes And Barriers
Block Grafts
Socket Preservation Materials
6.10. Global Regenerative Xenograft Market, Sub-Segmentation Of Vascular Xenografts, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Vascular Patches
Vascular Grafts
Heart Valve Xenografts
Pericardial Patches
7. Regenerative Xenograft Market Regional And Country Analysis
7.1. Global Regenerative Xenograft Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Regenerative Xenograft Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
